• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GLAXOSMITHKLINE DUNGARVAN LTD. COREGA SUPER CREMA; DENTURE ADHESIVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GLAXOSMITHKLINE DUNGARVAN LTD. COREGA SUPER CREMA; DENTURE ADHESIVE Back to Search Results
Lot Number V4084
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problem Death (1802)
Event Type  Injury  
Event Description
Accidental exposure to product [accidental exposure to product], misuse [device misuse], death due to unknown cause [death nos].Case description: this case was reported by a consumer via call center representative and described the occurrence of accidental exposure to product in a (b)(6) female patient who received triple salt dental adhesive cream (corega super crema) cream (batch number v4084, expiry date unk) for denture adhesion.Concurrent medical conditions included parkinson's disease and denture wearer, concomitant products included clonazepam.On an unknown date, the patient started corega super crema.On an unknown date, an unknown time after starting corega super crema, the patient experienced accidental exposure to product.On an unknown date, the outcome of the accidental exposure to product was unknown.It was unknown if the reporter considered the accidental exposure to product to be related to super corega crema.This report is made by gsk without prejudice and does not implant any admission or liability for the incident or its consequences.Additional details: this report refers to (b)(6) female consumer who has been using corega super crema for many years.She always used corega one time per day but lately she started applying it two times a day (although this is not recommended in product label).Consumer's daughter informed that the patient swallowed the product and residues remained in her throat.She consulted with a physician who informed that her digestive system is deteriorated because of old age.Also, she is a bedridden patient and has parkinson's disease.No more information was available.Follow-up was received on (b)(6) 2014.The patient's husband reported that his wife passed away.Date of death and cause of death were not reported.Case revision of original data: the patient received the double salt formulation of corega super.Creama and not the triple salt formulation of corega super crema as the triple salt formulation has been discontinued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COREGA SUPER CREMA
Type of Device
DENTURE ADHESIVE
Manufacturer (Section D)
GLAXOSMITHKLINE DUNGARVAN LTD.
dungarvan
EI 
Manufacturer (Section G)
GSK
Manufacturer Contact
po box 13398
research triangle park, NC 
MDR Report Key4877837
MDR Text Key6060693
Report Number9681138-2015-00025
Device Sequence Number1
Product Code KOL
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Type of Report Initial
Report Date 12/04/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/23/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Device Expiration Date02/27/2017
Device Lot NumberV4084
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Treatment
CLONAZEPAM, UNK
Patient Outcome(s) Death; Other;
Patient Age96 YR
Patient Weight56
-
-